Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Vogel

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
International Journal of Cardiology|May 31, 2017
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS RegistryMichela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology|June 13, 2024
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney DiseaseNader Mankerious, Ralph Toelg, Birgit Vogel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromesMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary InterventionMichela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology|August 6, 2017
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)Mikkel Schoos, Jaya Chandrasekhar, Usman Baber, et al.
JACC. Cardiovascular Interventions|November 10, 2018
Impact of On-Site Cardiac Surgery on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve ReplacementFlorian Egger, David Zweiker, Matthias K Freynhofer, et al.
International Journal of Cardiology|October 21, 2022
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stentMatteo Nardin, Carlo Andrea Pivato, Davide Cao, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
International Journal of Cardiology|May 31, 2017
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS RegistryMichela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology|June 13, 2024
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney DiseaseNader Mankerious, Ralph Toelg, Birgit Vogel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromesMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary InterventionMichela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology|August 6, 2017
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)Mikkel Schoos, Jaya Chandrasekhar, Usman Baber, et al.
JACC. Cardiovascular Interventions|November 10, 2018
Impact of On-Site Cardiac Surgery on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve ReplacementFlorian Egger, David Zweiker, Matthias K Freynhofer, et al.
International Journal of Cardiology|October 21, 2022
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stentMatteo Nardin, Carlo Andrea Pivato, Davide Cao, et al.
Pageof 19